Related Experiment Video

Updated: Mar 26, 2026

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

10.5K

Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner

Sung-Hak Kim1, Ravesanker Ezhilarasan2, Emma Phillips3

  • 1Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Cancer Cell
|February 10, 2016
PubMed

Insights

Mixed lineage kinase 4 (MLK4) activates nuclear factor κB (NF-κB) signaling in mesenchymal glioma stem cells (GSCs), driving tumor growth and radioresistance. Targeting MLK4 may offer a new strategy for treating this aggressive glioblastoma subtype.

Area of Science:

  • * Molecular oncology
  • * Cancer stem cell biology
  • * Glioblastoma research

Background:

  • * Nuclear factor κB (NF-κB) activation promotes mesenchymal (MES) transdifferentiation and radioresistance in glioma stem cells (GSCs).
  • * The upstream mechanisms regulating NF-κB activation in GSCs remain largely uncharacterized.
  • * Glioblastomas exhibit distinct molecular subtypes, including proneural (PN) and mesenchymal (MES), with differing clinical outcomes.

Purpose of the Study:

  • * To elucidate the molecular mechanisms underlying NF-κB activation in MES GSCs.
  • * To investigate the role of mixed lineage kinase 4 (MLK4) in GSC biology and glioblastoma pathogenesis.
  • * To determine the therapeutic potential of targeting MLK4 in specific glioblastoma subtypes.

Main Methods:

  • * Analysis of MLK4 expression in MES and PN GSCs.
  • * Functional studies involving MLK4 knockdown in MES GSCs, assessing self-renewal, motility, tumorigenesis, and radioresistance.
  • * Investigation of MLK4's interaction with and phosphorylation of IκB kinase α (IKKα).
  • * Correlation of MLK4 expression with patient prognosis in high-grade gliomas.

Main Results:

  • * Mixed lineage kinase 4 (MLK4) is significantly overexpressed in MES GSCs but not in PN GSCs.
  • * Silencing MLK4 abrogates self-renewal, motility, tumorigenesis, and radioresistance of MES GSCs by diminishing the MES gene signature.
  • * MLK4 directly binds to and phosphorylates IKKα, leading to the activation of NF-κB signaling.
  • * High MLK4 expression inversely correlates with poorer patient prognosis in the MES subtype of high-grade gliomas.

Conclusions:

  • * MLK4 functions as a critical upstream regulator of NF-κB signaling in MES GSCs.
  • * MLK4 drives key oncogenic properties, including radioresistance, in the MES glioblastoma subtype.
  • * MLK4 represents a promising molecular target for therapeutic intervention in mesenchymal glioblastomas.
Keywords:
cancer stem cellepithelial-to-mesenchymal transitionglioblastomaproneural-mesenchymal transition

More Related Videos

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion09:09

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Published on: April 12, 2020

7.5K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.0K